Lv4
460 积分 2026-07-21 加入
An orally available non-nucleotide STING agonist with antitumor activity
1天前
已完结
Macrophages in the process of osseointegration around the implant and their regulatory strategies
1天前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
International Endocervical Adenocarcinoma Criteria and Classification (IECC): An Independent Cohort With Clinical and Molecular Findings
3个月前
已完结
Molecular and microenvironmental landscapes of human papillomavirus-independent invasive squamous cell carcinoma of the vulva
3个月前
已完结
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
3个月前
已完结
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
3个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
3个月前
已完结
The evidence framework for precision cancer medicine
3个月前
已完结
皖公网安备34019202002308
